Business · 12/12/2018
FDA Releases Final Guidance on Biosimilars and BPCI Act
The FDA has released a final guidance document to inform prospective applicants and clarify FDA's interpretation of statutory requirements related to biosimilar development and the Biologics Price Competition and Innovation Act of 2009.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →